Granules India expects FDA nod for drug from Gagillapur facility by FY26 - Business News: Latest Share Market , Economy & Finance News | Trendmergers

Home industry Granules India expects FDA nod for drug from Gagillapur facility by FY26

Granules India expects FDA nod for drug from Gagillapur facility by FY26

industry,

It had voluntarily paused production in September

All Copyright @ Trendmergers Team

Crafted With By Templatesyard | Distributed By Gooyaabi Templates